Deputy Prime Minister and Finance Minister Chrystia Freeland held her first call with U.S. Vice-President Kamala Harris on Thursday, a discussion that touched on migration from Central America, the impact of the COVID-19 recession and the continued detention of two Canadians in China.
New Zealand's parliament has passed legislation giving mothers and their partners the right to paid leave following a miscarriage or still birth, becoming one of the few countries in the world to do so.
Jessica Walter, the Emmy-winning actor whose career spanned decades, has died. She was 80.
Carbon pricing didn't just win a big endorsement from Canada's Supreme Court on Thursday — it's also receiving surprising new support from a new corner in the U.S.: the American oil lobby. Ironically, this new support for carbon pricing comes as U.S. climate policy is shifting elsewhere.
U.S. President Joe Biden opened his first formal news conference Thursday with a nod toward the improving picture on battling the coronavirus, but he was immediately pressed on thorny issues, such as immigration and voting rights, now testing his administration.
The torch relay for the postponed Tokyo Olympics began its 121-day journey across Japan on Thursday and is headed toward the opening ceremony in Tokyo on July 23.
North Korea on Thursday test-fired its first ballistic missiles since U.S. President Joe Biden took office, as it expands its military capabilities and increases pressure on Washington while nuclear negotiations remain stalled.
A skyscraper-sized cargo ship wedged across Egypt's Suez Canal further imperilled global shipping Thursday as at least 150 other vessels needing to pass through the crucial waterway idled waiting for the obstruction to clear, authorities said.
It's the hottest debate in U.S. politics — one potential rule change that could change everything when it comes to passing laws in Congress. The Senate's filibuster rule has created a graveyard of bills over the years. Democrats could now be on the cusp of reforming it to save Joe Biden's agenda.
AstraZeneca said its COVID-19 vaccine had a 76 per cent efficacy rate at preventing symptomatic illness in a new analysis of its major U.S. trial — slightly lower than the level announced earlier this week in a report that was criticized for using outdated information.
